BN 80245: An E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activities

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 17, 1997, Pages 2235-2238

  Lavergne, Olivier ^a   Lesueur Ginot, Laurence ^a   Rodas, Francesc Pla ^b   Bigg, Dennis C H ^a  

^a Institut Henri Beaufour   (France)

^b Laboratorios Lasa   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BN 80245; CAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; DNA TOPOISOMERASE; TOPOTECAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; LEUKEMIA CELL; MOUSE; NONHUMAN;

EID: 0030931517     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00398-3     Document Type: Article

References (29)

1. Hsiang, Y. H.; Liu, L. F. Cancer Res. 1988, 48, 1722-1726. Hsiang, Y. H.; Liu, L. F.; Wall, M. E.; Wani, M. C.; Nicholas, A. W.; Manikumar, G.; Kirschenbaum, S.; Silber, R; Potmesil, M. Cancer Res. 1989, 49, 4385-4389.
2. Hsiang, Y. H.; Liu, L. F. Cancer Res. 1988, 48, 1722-1726. Hsiang, Y. H.; Liu, L. F.; Wall, M. E.; Wani, M. C.; Nicholas, A. W.; Manikumar, G.; Kirschenbaum, S.; Silber, R; Potmesil, M. Cancer Res. 1989, 49, 4385-4389.
3. Dancey, J.; Eisenhauer, E. A. Br. J. Cancer 1996, 74, 327-338 and references cited therein.
4. Sawada, S.; Matsuoka, S.; Nokata, K.; Nagata, H.; Furuta, T.; Yokokura, T.; Miyasaka, T. Chem. Pharm. Bull. 1991, 39, 3183-3188. Shirao, K.; Shimada, Y.; Kondo, H.; Saito, D.; Yamao, T.; Ono, H.; Yokoyama, T.; Fukuda, H.; Oka, M.; Watanabe, Y.; Ohtsu, A.; Boku, N.; Fujii, T.; Oda, Y.; Muro, K.; Yoshida, S. J. Clin. Oncol. 1997, 15, 921-927. See also Drugs Fut. 1995, 20, 307-310 and references cited therein.
5. Sawada, S.; Matsuoka, S.; Nokata, K.; Nagata, H.; Furuta, T.; Yokokura, T.; Miyasaka, T. Chem. Pharm. Bull. 1991, 39, 3183-3188. Shirao, K.; Shimada, Y.; Kondo, H.; Saito, D.; Yamao, T.; Ono, H.; Yokoyama, T.; Fukuda, H.; Oka, M.; Watanabe, Y.; Ohtsu, A.; Boku, N.; Fujii, T.; Oda, Y.; Muro, K.; Yoshida, S. J. Clin. Oncol. 1997, 15, 921-927. See also Drugs Fut. 1995, 20, 307-310 and references cited therein.
6. Sawada, S.; Matsuoka, S.; Nokata, K.; Nagata, H.; Furuta, T.; Yokokura, T.; Miyasaka, T. Chem. Pharm. Bull. 1991, 39, 3183-3188. Shirao, K.; Shimada, Y.; Kondo, H.; Saito, D.; Yamao, T.; Ono, H.; Yokoyama, T.; Fukuda, H.; Oka, M.; Watanabe, Y.; Ohtsu, A.; Boku, N.; Fujii, T.; Oda, Y.; Muro, K.; Yoshida, S. J. Clin. Oncol. 1997, 15, 921-927. See also Drugs Fut. 1995, 20, 307-310 and references cited therein.
7. Kingsburry, W. D.; Boehm, J. C.; Jakas, D. R.; Holden, K. G.; Hecht, S. M.; Gallagher, G.; Caranfa, M. J.; McCabe, F. L.; Faucette, L. F.; Johnson, R. K.; Hertzberg, R. P. J. Med. Chem. 1991, 34, 98-107. Creemers, G. J.; Gerrits, C. J. H.; Eckardt, J. R.; Schellens, J. H. M.; Burris, H. A.; Planting, A. S. T.; Rodriguez, G. I.; Loos, W. J.; Hudson, I.; Broom, C.; Verweij, J.; Von Hoff, D. D. J. Clin. Oncol. 1997, 15, 1087-1093. See also Drugs Fut. 1996, 21, 570-574 and references cited therein.
8. Kingsburry, W. D.; Boehm, J. C.; Jakas, D. R.; Holden, K. G.; Hecht, S. M.; Gallagher, G.; Caranfa, M. J.; McCabe, F. L.; Faucette, L. F.; Johnson, R. K.; Hertzberg, R. P. J. Med. Chem. 1991, 34, 98-107. Creemers, G. J.; Gerrits, C. J. H.; Eckardt, J. R.; Schellens, J. H. M.; Burris, H. A.; Planting, A. S. T.; Rodriguez, G. I.; Loos, W. J.; Hudson, I.; Broom, C.; Verweij, J.; Von Hoff, D. D. J. Clin. Oncol. 1997, 15, 1087-1093. See also Drugs Fut. 1996, 21, 570-574 and references cited therein.
9. Kingsburry, W. D.; Boehm, J. C.; Jakas, D. R.; Holden, K. G.; Hecht, S. M.; Gallagher, G.; Caranfa, M. J.; McCabe, F. L.; Faucette, L. F.; Johnson, R. K.; Hertzberg, R. P. J. Med. Chem. 1991, 34, 98-107. Creemers, G. J.; Gerrits, C. J. H.; Eckardt, J. R.; Schellens, J. H. M.; Burris, H. A.; Planting, A. S. T.; Rodriguez, G. I.; Loos, W. J.; Hudson, I.; Broom, C.; Verweij, J.; Von Hoff, D. D. J. Clin. Oncol. 1997, 15, 1087-1093. See also Drugs Fut. 1996, 21, 570-574 and references cited therein.
10. Wani, M. C.; Nicholas, A. W.; Wall, M. E. J. Med. Chem. 1986, 29, 2358-2363. See also Robinson, C.; Robinson, K.; Castañer J. Drugs Fut. 1996, 21, 881-889 and references cited therein.
11. Wani, M. C.; Nicholas, A. W.; Wall, M. E. J. Med. Chem. 1986, 29, 2358-2363. See also Robinson, C.; Robinson, K.; Castañer J. Drugs Fut. 1996, 21, 881-889 and references cited therein.
12. Luzzio, M. J.; Besterman, J. M.; Emerson, D. L.; Evans, M. G.; Lackey, K.; Leitener, P.; McIntyre, G.; Morton, B.; Myers, P. L.; Peel, M. R.; Sisco, J. M.; Sternbach, D. D.; Tong, W.-Q.; Truesdale, A.; Uehling, D. E.; Vuong, A.; Yates, J. J. Med. Chem. 1995, 38, 395-401.
13. Mitsui, I.; Kumazawa, E.; Hirota, Y.; Aonuma, M.; Sugimori, M.; Ohsuki, S.; Uoto, K.; Ejima, A.; Terasawa, H.; Sato, K. Jpn. J. Cancer Res. 1995, 86, 776-782.
14. Wall, M. E.; Wani, M. C.; Nicholas, A. W.; Manikumar, G.; Tele, C.; Moore, L.; Truesdale, A.; Leitner, P.; Besterman, J. M. J. Med. Chem. 1993, 36, 2689-2700. Sawada, S.; Yokokura, T.; Miyasaka, T. Current Pharmaceutical Design, 1995, 1, 113-132. Peel, M. R.; Milstead, M. W.; Sternbach, D. D.; Besterman, J. M.; Leitner, P.; Morton, B.; Wall, M. E.; Wani, M. C. Bioorg. Med. Chem. Lett. 1995, 5, 2129-2132.
15. Wall, M. E.; Wani, M. C.; Nicholas, A. W.; Manikumar, G.; Tele, C.; Moore, L.; Truesdale, A.; Leitner, P.; Besterman, J. M. J. Med. Chem. 1993, 36, 2689-2700. Sawada, S.; Yokokura, T.; Miyasaka, T. Current Pharmaceutical Design, 1995, 1, 113-132. Peel, M. R.; Milstead, M. W.; Sternbach, D. D.; Besterman, J. M.; Leitner, P.; Morton, B.; Wall, M. E.; Wani, M. C. Bioorg. Med. Chem. Lett. 1995, 5, 2129-2132.
16. Wall, M. E.; Wani, M. C.; Nicholas, A. W.; Manikumar, G.; Tele, C.; Moore, L.; Truesdale, A.; Leitner, P.; Besterman, J. M. J. Med. Chem. 1993, 36, 2689-2700. Sawada, S.; Yokokura, T.; Miyasaka, T. Current Pharmaceutical Design, 1995, 1, 113-132. Peel, M. R.; Milstead, M. W.; Sternbach, D. D.; Besterman, J. M.; Leitner, P.; Morton, B.; Wall, M. E.; Wani, M. C. Bioorg. Med. Chem. Lett. 1995, 5, 2129-2132.
17. Crow, R. T.; Crothers, D. M.; J. Med. Chem. 1992, 35, 4160-4164. Wall, M. E.; Wani, M. C. Cancer Res. 1995, 55, 753-760. Wall, M. E., Wani, M. C. In Camptothecins: New Anticancer Agents; Potmesil, M.; Pinedo, H., Eds.; CRC Press: Boca Raton, 1995; pp 21-41.
18. Crow, R. T.; Crothers, D. M.; J. Med. Chem. 1992, 35, 4160-4164. Wall, M. E.; Wani, M. C. Cancer Res. 1995, 55, 753-760. Wall, M. E., Wani, M. C. In Camptothecins: New Anticancer Agents; Potmesil, M.; Pinedo, H., Eds.; CRC Press: Boca Raton, 1995; pp 21-41.
19. Crow, R. T.; Crothers, D. M.; J. Med. Chem. 1992, 35, 4160-4164. Wall, M. E.; Wani, M. C. Cancer Res. 1995, 55, 753-760. Wall, M. E., Wani, M. C. In Camptothecins: New Anticancer Agents; Potmesil, M.; Pinedo, H., Eds.; CRC Press: Boca Raton, 1995; pp 21-41.
20. Hertzberg, R. P.; Caranfa, M. J.; Hecht, S. M. Biochemistry, 1989, 28, 4629-4638.
21. Govindachari, T. R.; Ravindranath, K. R.; Viswanathan, N. J. J. Chem. Soc., Perkin Trans. I 1974, 1215-1217. See also Allaudeen, H. S.; Berges, D. A.; Hertzberg, R. P.; Jonhson, R. K.; Kingsbury, W. D.; Petteway, S. R. Jr. PCT Int. Appl. WO 92/07856.
22. Govindachari, T. R.; Ravindranath, K. R.; Viswanathan, N. J. J. Chem. Soc., Perkin Trans. I 1974, 1215-1217. See also Allaudeen, H. S.; Berges, D. A.; Hertzberg, R. P.; Jonhson, R. K.; Kingsbury, W. D.; Petteway, S. R. Jr. PCT Int. Appl. WO 92/07856.
23. All new compounds gave satisfactory analysis and spectroscopic data consistent with the proposed structure.
24. Mi, Z.; Burke, T. G. Biochemistry 1994, 34, 10325-10336.
25. Jaxel, C.; Kohn, K. W.; Wani, M. C.; Wall, M. E.; Pommier, Y. Cancer Res. 1989, 49, 1465-1469. The DNA relaxation assay was performed using pUC19 plasmid DNA and purified calf thymus topoisomerase I provided by Life Technologies SARL (Cergy-Pontoise, France) in the recommanded incubation conditions.
26. Mosmann, T. J. Imumunol. Methods 1983, 63, 55-63.
27. Bedeschi, A.; Zarini, F.; Cabri, W.; Candiani, I.; Penco, S.; Capolongo, L.; Ciomei, M.; Farao, M.; Grandi, M. Bioorg. Med. Chem. Lett. 1996, 6, 671-674.
28. Hertzberg, R. P.; Caranfa, M. J.; Holden, K. G.; Jakas, D. R.; Gallagher, G.; Matter, M. R.; Mong, S.-M.; Bartus, J. O.; Johnson, R. K.; Kingsbury, W. D. J. Med. Chem. 1989, 32, 715-720.
29. A 18-noranhydrocamptothecin has been reported to retain enzyme inhibitory function, but with significantly reduced cytotoxicity: Snyder, L.; Shen, W.; Bornmann, W. G.; Danishefsky, S. J. J. Org. Chem. 1994, 59, 7033-7037.